Gogu Anca Elena, Jianu Dragos Catalin, Parv Florina, Motoc Andrei Gheorghe Marius, Axelerad Any, Stuparu Alina Zorina, Gogu Andreea Alexandra
Department of Neurology, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania.
Centre for Cognitive Research in Neuropsychiatric Pathology (Neuropsy-Cog), Faculty of Medicine, "Victor Babeş" University of Medicine and Pharmacy, Timișoara, Romania.
Front Neurol. 2024 Jan 5;14:1320757. doi: 10.3389/fneur.2023.1320757. eCollection 2023.
Kearns-Sayre syndrome (KSS) is classified as one of the mitochondrial DNA (mtDNA) deletion syndromes with multisystemic involvement. Additionally, the negative prognosis is associated with inherited thrombophilia, which includes the presence of homozygous Factor V G1691A Leiden mutation, MTHFR gene polymorphisms C677T and A1298C, and PAI-1 675 homozygous genotype 5G/5G.
This case report presents a 48-year-old man with chronic progressive external ophthalmoplegia, bilateral ptosis, cerebellar ataxia, cardiovascular signs (syncope, dilated cardiomyopathy, and cardiac arrest) with electrocardiographic abnormalities (first-degree atrioventricular block and major right bundle branch block), endocrine dysfunction (short stature, growth hormone insufficiency, primary gonadal insufficiency, hypothyroidism, and secondary hyperparathyroidism), molecular genetic tests (MT-TL2 gene), and abnormal MRI brain images, thus leading to the diagnosis of KSS. The patient came back 4 weeks after the diagnosis to the emergency department with massive bilateral pulmonary embolism with syncope at onset, acute cardiorespiratory failure, deep left femoral-popliteal vein thrombophlebitis, and altered neurological status. In the intensive care unit, he received mechanical ventilation through intubation. Significant improvement was seen after 2 weeks. The patient tested positive for inherited thrombophilia and was discharged in stable conditions on a new treatment with Rivaroxaban 20 mg/day. At 6 months of follow-up, ECG-Holter monitoring and MRI brain images remained unchanged. However, after 3 months, the patient died suddenly while sleeping at home.
The genetic tests performed on KSS patients should also include those for inherited thrombophilia. By detecting these mutations, we can prevent major complications such as cerebral venous sinus thrombosis, coronary accidents, or sudden death.
卡恩斯-塞尔综合征(KSS)被归类为线粒体DNA(mtDNA)缺失综合征之一,累及多系统。此外,不良预后与遗传性易栓症有关,遗传性易栓症包括纯合子因子V G1691A莱顿突变、亚甲基四氢叶酸还原酶(MTHFR)基因多态性C677T和A1298C以及纤溶酶原激活物抑制剂-1(PAI-1)675纯合子基因型5G/5G。
本病例报告介绍了一名48岁男性,患有慢性进行性眼外肌麻痹、双侧上睑下垂、小脑共济失调、心血管体征(晕厥、扩张型心肌病和心脏骤停)伴心电图异常(一度房室传导阻滞和主要右束支传导阻滞)、内分泌功能障碍(身材矮小、生长激素不足、原发性性腺功能不全、甲状腺功能减退和继发性甲状旁腺功能亢进)、分子遗传学检测(MT-TL2基因)以及脑部MRI图像异常,从而诊断为KSS。该患者在确诊后4周因大规模双侧肺栓塞伴起病时晕厥、急性心肺衰竭、左股腘深静脉血栓性静脉炎和神经状态改变返回急诊科。在重症监护病房,他通过插管接受机械通气。2周后病情显著改善。该患者遗传性易栓症检测呈阳性,出院时病情稳定,开始接受利伐沙班20毫克/天的新治疗。在6个月的随访中,心电图动态监测和脑部MRI图像保持不变。然而,3个月后,患者在家中睡觉时突然死亡。
对KSS患者进行的基因检测还应包括遗传性易栓症检测。通过检测这些突变,我们可以预防诸如脑静脉窦血栓形成、冠状动脉意外或猝死等重大并发症。